BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27855403)

  • 1. FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis.
    Chen X; Duan LH; Luo PC; Hu G; Yu X; Liu J; Lu H; Liu B
    Cell Physiol Biochem; 2016; 39(6):2501-2508. PubMed ID: 27855403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.
    Liu B; Zheng Y; Wang TD; Xu HZ; Xia L; Zhang J; Wu YL; Chen GQ; Wang LS
    J Proteome Res; 2012 Mar; 11(3):1773-81. PubMed ID: 22268729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO6 attenuates cadmium toxicity in HEK293 cells by inhibiting ER stress and JNK activation.
    Du K; Takahashi T; Kuge S; Naganuma A; Hwang GW
    J Toxicol Sci; 2014; 39(6):861-6. PubMed ID: 25374377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer.
    Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Liu B
    Cell Death Dis; 2021 Mar; 12(4):317. PubMed ID: 33767133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer.
    Zhang J; Yang J; Lin C; Liu W; Huo Y; Yang M; Jiang SH; Sun Y; Hua R
    Theranostics; 2020; 10(18):8400-8414. PubMed ID: 32724477
    [No Abstract]   [Full Text] [Related]  

  • 6. Fbxo6 confers drug-sensitization to cisplatin via inhibiting the activation of Chk1 in non-small cell lung cancer.
    Cai L; Li J; Zhao J; Guo Y; Xie M; Zhang X; Wang L; Tian H; Li A; Li Q; Miao Y
    FEBS Lett; 2019 Jul; 593(14):1827-1836. PubMed ID: 31140586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
    Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
    FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncanonical Role of FBXO6 in Regulating Antiviral Immunity.
    Du X; Meng F; Peng D; Wang Z; Ouyang W; Han Y; Gu Y; Fan L; Wu F; Jiang X; Xu F; Qin FX
    J Immunol; 2019 Aug; 203(4):1012-1020. PubMed ID: 31308089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases.
    Glenn KA; Nelson RF; Wen HM; Mallinger AJ; Paulson HL
    J Biol Chem; 2008 May; 283(19):12717-29. PubMed ID: 18203720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel RING finger E3 ligase RNF186 regulate ER stress-mediated apoptosis through interaction with BNip1.
    Wang P; Wu Y; Li Y; Zheng J; Tang J
    Cell Signal; 2013 Nov; 25(11):2320-33. PubMed ID: 23896122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
    Qiao Y; Zhang Y; Wang J
    Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma.
    Hayes KE; Batsomboon P; Chen WC; Johnson BD; Becker A; Eschrich S; Yang Y; Robart AR; Dudley GB; Geldenhuys WJ; Hazlehurst LA
    Bioorg Med Chem; 2019 Apr; 27(8):1479-1488. PubMed ID: 30850265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCF-FBW7β E3 ligase mediates ubiquitination and degradation of the serine/threonine protein kinase PINK1.
    Jeon SJ; Chung KC
    J Biol Chem; 2024 Apr; 300(4):107198. PubMed ID: 38508312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of peptide:
    Yoshida Y; Asahina M; Murakami A; Kawawaki J; Yoshida M; Fujinawa R; Iwai K; Tozawa R; Matsuda N; Tanaka K; Suzuki T
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34215698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
    Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
    Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCF
    Sugiyama S; Yumimoto K; Inoue I; Nakayama KI
    Genes Cells; 2019 May; 24(5):354-365. PubMed ID: 30838725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein-specific ubiquitin ligases recognize N-glycans in unfolded substrates.
    Yoshida Y; Adachi E; Fukiya K; Iwai K; Tanaka K
    EMBO Rep; 2005 Mar; 6(3):239-44. PubMed ID: 15723043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic regulation of metabolic enzymes by E3 ubiquitin ligase complexes: lessons from yeast.
    Nakatsukasa K; Okumura F; Kamura T
    Crit Rev Biochem Mol Biol; 2015; 50(6):489-502. PubMed ID: 26362128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.